A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
Cristina Papayannidis(University of Bologna), Giovanni Martinelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 119